help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Summerlee, A. J. S.
Right arrow Articles by Ramsey, D. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Summerlee, A. J. S.
Right arrow Articles by Ramsey, D. G.
Endocrinology Vol. 139, No. 5 2322-2328
Copyright © 1998 by The Endocrine Society

ARTICLES

The Dipsogenic Effects of Rat Relaxin: The Effect of Photoperiod and the Potential Role of Relaxin on Drinking in Pregnancy1

A. J. S. Summerlee, D. J. Hornsby2 and D. G. Ramsey

Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Ontario N1G 2W1 Canada

Address all correspondence and requests for reprints to: Dr. Alastair J. S. Summerlee, Office of the Dean of Graduate Studies, University Centre, University of Guelph, Guelph N1G 2W1, Ontario, Canada. E-mail: alastair{at}exec.admin.uoguelph.ca

Experiments were done to examine whether rat relaxin is dipsogenic and whether such dipsogenic effects of rat relaxin are related to time of injection during the light-dark cycle. Female rats were fitted with a chronic intra-cerebro-ventricular (icv) cannula. Rat relaxin (2.5, 5, 10, 25, 50, or 100 ng/2 µl in 0.9% saline) was injected into the right lateral ventricle at either morning (0800–1000 h), afternoon (1400–1600 h), or night (2200–2400 h), and water consumption was measured. Relaxin caused a dose-dependent dipsogenesis at doses >= 5 ng, but the sensitivity and magnitude of the response varied with the photoperiod. Water consumption was smallest (3.5 ± 0.7 ml at 50 ng) and least sensitive (minimal effective dose at 25 ng) in the afternoon and maximal (17.7 ± 2.3 ml at 50 ng) and most sensitive (minimal effective dose 5 ng) at night. The latency from injection to drinking was 55.8 ± 10.4 sec (mean ± SEM) and did not vary significantly with either the dose or time of day.

A second set of experiments was done to examine the effects of neutralizing the central actions of relaxin on drinking behavior in pregnancy. Pregnant rats were injected daily, through a chronically implanted icv cannula, with either a specific monoclonal antibody raised against rat relaxin from day 12 to day 22 of gestation or with saline as a control. Drinking and eating behavior and weight gain were monitored every 12 h during pregnancy. There was a significant decrease in water consumed at night, but no effect on drinking during the day in relaxin-neutralized rats. These animals also showed a decrease in weight gain during pregnancy compared with controls and gave birth to lighter-weight litters.

These data provide evidence that the dipsogenic response to exogenous rat relaxin in female rats varies with time of injection during the light-dark cycle and suggest that relaxin in the brain may have a role in nighttime drinking behavior during the second half of pregnancy.




This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
K. Santora, C. Rasa, D. Visco, B. G. Steinetz, and C. A. Bagnell
Antiarthritic Effects of Relaxin, in Combination with Estrogen, in Rat Adjuvant-Induced Arthritis
J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 887 - 893.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
R. A. Bathgate, R. Ivell, B. M. Sanborn, O. D. Sherwood, and R. J. Summers
International Union of Pharmacology LVII: Recommendations for the Nomenclature of Receptors for Relaxin Family Peptides.
Pharmacol. Rev., March 1, 2006; 58(1): 7 - 31.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
M. J. Cairns, P. Burns, R. Di Nicolantonio, M. J. McKinley, and M. L. Mathai
Influence of brain angiotensin on thermoregulation and hydromineral balance during pregnancy in rats
J Appl Physiol, May 1, 2005; 98(5): 1813 - 1819.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
O. D. Sherwood
Relaxin's Physiological Roles and Other Diverse Actions
Endocr. Rev., April 1, 2004; 25(2): 205 - 234.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
L. A. Danielson, L. J. Kercher, and K. P. Conrad
Impact of gender and endothelin on renal vasodilation and hyperfiltration induced by relaxin in conscious rats
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2000; 279(4): R1298 - R1304.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
P. Sinnayah, P. Burns, J. D. Wade, R. S. Weisinger, and M. J. McKinley
Water Drinking in Rats Resulting from Intravenous Relaxin and Its Modification by Other Dipsogenic Factors
Endocrinology, November 1, 1999; 140(11): 5082 - 5086.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
R. A. D. Bathgate, C. S. Samuel, T. C. D. Burazin, S. Layfield, A. A. Claasz, I. G. T. Reytomas, N. F. Dawson, C. Zhao, C. Bond, R. J. Summers, et al.
Human Relaxin Gene 3 (H3) and the Equivalent Mouse Relaxin (M3) Gene. NOVEL MEMBERS OF THE RELAXIN PEPTIDE FAMILY
J. Biol. Chem., January 4, 2002; 277(2): 1148 - 1157.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1998 by The Endocrine Society